PolyPeptide Group | Finanzwire

Basculer en Français

8296	Companies
114902	Keywords
55328	Articles
62458	Press releases

Home
Companies
PolyPeptide Group

BRIEF

published on 08/13/2024 at 07:05, 3 months 8 days ago

PolyPeptide Group Reports Solid Progress and Upgrades FY 2024 Guidance

Revenue Growth Capacity Expansion EBITDA Improvement PolyPeptide Group H1 2024 Results
PRESS RELEASE

published on 08/13/2024 at 07:00, 3 months 8 days ago

Solid progress in H1 2024 – Upgrade of 2024 full-year guidance – Mid-term target to double 2023 revenue by 2028
PolyPeptide Group AG reports solid progress in H1 2024 with upgraded full-year guidance and mid-term target to double 2023 revenue by 2028. Revenue growth driven by commercial activities and operational improvements

Revenue Growth PolyPeptide Group AG Full-year Guidance H1 2024 Mid-term Target
BRIEF

published on 08/08/2024 at 20:05, 3 months 12 days ago

PolyPeptide appoints Chief Commercial Officer

Chief Commercial Officer PolyPeptide Stéphane Varray Pharmaceutical Ingredients GLP-1 Therapies
PRESS RELEASE

published on 08/08/2024 at 20:00, 3 months 12 days ago

PolyPeptide appoints Chief Commercial Officer
PolyPeptide Group AG announces the appointment of Stéphane Varray as Chief Commercial Officer and member of the Management Committee, effective January 2025

Growth Strategy Pharmaceuticals Chief Commercial Officer PolyPeptide Stéphane Varray
BRIEF

published on 04/10/2024 at 19:28, 7 months 10 days ago

PolyPeptide Announces Positive Outcomes at 2024 Annual General Meeting

Shareholder Approval Corporate Governance Annual General Meeting 2024 PolyPeptide Group Financial Statements 2023
PRESS RELEASE

published on 04/10/2024 at 19:23, 7 months 10 days ago

PolyPeptide announces results of the annual General Meeting 2024
PolyPeptide Group AG announces successful approval of all proposals at annual General Meeting 2024. Details include re-election of Board members and approval of key financial matters

Board Of Directors Annual General Meeting Shareholders PolyPeptide Group AG Financial Approvals
BRIEF

published on 03/19/2024 at 07:05, 8 months 2 days ago

PolyPeptide Group Announces Annual General Meeting 2024

Board Of Directors Annual General Meeting Pharmaceutical Industry Corporate Governance PolyPeptide Group
PRESS RELEASE

published on 03/19/2024 at 07:00, 8 months 2 days ago

PolyPeptide publishes invitation to the annual General Meeting 2024
PolyPeptide Group AG publishes invitation to the annual General Meeting 2024 with details of proposed agenda items and changes to the Board of Directors

Board Of Directors Annual General Meeting 2024 AGM 2024 PolyPeptide Group AG Remuneration Committee
BRIEF

published on 03/12/2024 at 06:50, 8 months 9 days ago

PolyPeptide Announces Record Revenue Growth in Second Half of 2023

Operational Improvements Revenue Growth Financial Performance Pharmaceuticals PolyPeptide Group
PRESS RELEASE

published on 03/12/2024 at 06:45, 8 months 9 days ago

PolyPeptide with record revenue growth of 43% in H2 2023 versus H1 2023; operational improvements yielding increased profitability and cash flow
PolyPeptide announces record revenue growth of 43% in H2 2023 compared to H1 2023, along with enhanced profitability and cash flow. Details on 2023 results and 2024 guidance provided

Revenue Growth Cash Flow Profitability 2023 Results PolyPeptide

Accesswire

Published on 11/21/2024 at 13:30, 10 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 10 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 40 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 40 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 40 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 25 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 5 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 25 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 34 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 40 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 42 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 20 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 55 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 55 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE